The short version
Wellorithm is a flat-rate telehealth provider. It has no rankable price in our database as of September 4, 2026; it is listed so the candidate universe is complete. Verification status: unverified.
The numbers, plan by plan
- Tirzepatide (standard, month-to-month plan): no rankable price. No price published; quoted after intake per a third-party directory.
Fees and what the price includes
Whether a separate membership or program fee applies has not been confirmed, and the ranking rows say so. Shipping terms are not published in the sources we hold. Consultation terms are not published. Whether the price changes with dose is not confirmed.
How this pricing structure plays out over a year
Because Wellorithm has no rankable price, the structure below is what a patient should expect to reconstruct from its checkout: the recurring medication price at the starting and highest dose, any membership or program fee and its introductory rate, the plan length behind any headline figure, and what happens to the price at renewal. Until those are published or captured, the twelve-month cost cannot be stated, and we do not guess it.
Compared with the field
Wellorithm is not ranked, so it has no position in the field; it will enter the ranking automatically when a price is verified.
Pharmacy, coverage and cancellation
The provider reports serving all fifty states. The dispensing pharmacy and its 503A or 503B status are not published; ask at intake and verify the license. Commitment: month-to-month reported. Cancellation: not captured.
Questions to ask Wellorithm before paying
Ask, in writing: Which pharmacy fills the prescription, is it 503A or 503B, and can I see a certificate of analysis for my batch? Is there any membership, program, consultation or shipping fee beyond the medication price? How do I cancel, how much notice is required, and is there a fee? Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
All 50 states reported.
What to weigh against it
No published price; quoted after intake, which prevents comparison before disclosure of personal information.
Who should choose Wellorithm
Not recommended for price comparison until a price is published. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
Is Wellorithm legitimate? What we can verify
Wellorithm operates as a telehealth prescriber: a licensed clinician reviews an intake and issues a prescription, and a pharmacy fills it. That is the lawful model, and it is the same model every provider on this site uses; the questions that separate a legitimate operation from a risky one are whether the price is published before intake, whether the pharmacy is named, whether the prescription documents a clinical reason for a compounded product, and whether the company answers questions in writing. Its prices could not be pinned down from its own pages, which is a transparency failure rather than evidence of wrongdoing. It does not publicly name its dispensing pharmacy, so a patient cannot verify the license without asking. We have no evidence of a scam, and we do not use the word for any provider that prescribes on a valid prescription and ships from a licensed pharmacy; LegitScript certification, BBB profiles and state-board actions are not yet captured in our data and are listed as checks a patient can make.
Wellorithm complaints and reputation
We have not yet analyzed public reviews of Wellorithm for complaint patterns; the reputation index explains the method (shipping, billing and refund, provider access, support, and dosing-instruction complaints as shares of recent reviews). Until it is run, the useful checks are Trustpilot and the Better Business Bureau for volume and recency, and Reddit threads for the specific failure modes patients describe: shipments that arrive warm, charges after cancellation, clinicians who do not answer, and dosing sheets that do not match the vial.
Fees, HSA/FSA and promotions
No introductory or promotional price is recorded; we do not publish promotional codes. HSA/FSA eligibility is not captured; most telehealth GLP-1 programs can issue itemized receipts for FSA/HSA reimbursement, but eligibility of compounded medication depends on the plan administrator. Consultation fees are not published.
Consultation, labs, refills and shipping
Consultation type (video, phone or asynchronous questionnaire) is not captured in our data; most compounded-GLP-1 telehealth intakes are asynchronous with a clinician follow-up, and a patient who needs a video visit should ask. Lab requirements are not captured; many providers accept recent labs and some require none for compounded GLP-1s, while brand-name and insurance-first programs more often require them. Refill process is not captured; ask how a dose increase is requested, how many days before the next dose a refill ships, and whether a new visit is required. Shipping terms and typical transit time are not published.
Alternatives to Wellorithm
Alternatives worth comparing: NexLife has the highest value score for tirzepatide (92) at $1,668 for twelve months; Trimi has the lowest twelve-month total ($1,500, verified). Side-by-side: Wellorithm vs NexLife.
Update history
No price changes or corrections have been logged for Wellorithm since tracking began on August 25, 2026. Any future change appears on the price history page with the date, old figure, new figure and source.
How we verified this
No first-party page exposing exact prices or a named pharmacy was found; secondary listings cite about $147 for semaglutide and $249 for tirzepatide, which is insufficient for verification. Unranked. Verified against the provider's own pages on 2026-09-04 (first-party verification pass).